drug · antibody
balstilimab
Phase 2updated 5mo agoby $AGEN AGENUS INC🔗 ChEMBL
Phase 2community read0 votes
Antibody drug with a maximum clinical stage of Phase 3 (across all indications), with 11 investigational indications.
targets
Programmed cell death protein 1
all catalysts(0)
nothing on the calendar yet
Trials studying balstilimab
- phase2Phase 2a Immune Modulation With Ultrasound for Newly Diagnosed Glioblastoma
- phase2A Study of Zalifrelimab and Balstilimab for Treatment of Participants With Metastatic or Locally Advanced Solid Tumors, and Expansion Into Select Solid Tumors (Cervical)
- phase2RECTIFY-1: Neoadjuvant Botensilimab + Balstilimab in MSS/pMMR Early Rectal Cancer
- phase3Botensilimab + Balstilimab vs Best Supportive Care as Therapy in Chemo-refractory, Unresectable, Colorectal Adenocarcinoma
- phase2BALSTILIMAB on Viral Clearance in HPV+ Oropharyngeal Cancer Patients
- phase3Combination of Immune Checkpoint in Locally Advanced or Metastatic MSI/dMMR Esogastric Adenocarcinomas
- phase2Doxorubicin Plus Dual Checkpoint Blockade for Soft Tissue Sarcomas
- EP1Botensilimab, Balstilimab, and SBRT in Colorectal Cancer
News(2)
- 5 drugmakers chasing Merck and Moderna in the cancer vaccine raceFollowing their blowout win in melanoma last month, Merck and Moderna are leading the way among a new crop of personalized cancer vaccines. Here are five companies with similar therapies hoping to…biospace · 19d ago
- Solstice rises with $225M series A to advance next-gen CTLA-4 immunotherapy into phase 2Solstice Oncology has secured $225 million in series A funding to advance a next-gen immunotherapy that the biotech hopes will turn “darkness to light” for cancer care.fiercebiotech · 25d ago
Data sources
last refreshed 3h ago
Found something off?
comments(0)
5-min edit window · permanent after that